Patents by Inventor John D. Cusmano

John D. Cusmano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD40 ANTIBODY FORMULATION AND METHODS
    Publication number: 20120263732
    Abstract: The present invention provides a method of treating tumor in a patient comprising administering to said patient a CD40 agonist antibody according to an intermittent dosing schedule. The present invention also provides a method of treating tumor in a patient comprising administering a combination of a CD40 agonist antibody and a DNA replication inhibitor. Also provided is a formulation for use in the treatment.
    Type: Application
    Filed: March 19, 2012
    Publication date: October 18, 2012
    Inventors: Ronald P. Gladue, John D. Cusmano, Vahe Bedian
  • CD40 ANTIBODY FORMULATION AND METHODS
    Publication number: 20110104182
    Abstract: The present invention provides a method of treating tumor in a patient comprising administering to said patient a CD40 agonist antibody according to an intermittent dosing schedule. The present invention also provides a method of treating tumor in a patient comprising administering a combination of a CD40 agonist antibody and a DNA replication inhibitor. Also provided is a formulation for use in the treatment.
    Type: Application
    Filed: December 23, 2010
    Publication date: May 5, 2011
    Inventors: Ronald P. Gladue, John D. Cusmano, Vahe Bedian
  • CD40 ANTIBODY FORMULATION AND METHODS
    Publication number: 20090311254
    Abstract: The present invention provides a method of treating tumor in a patient comprising administering to said patient a CD40 agonist antibody according to an intermittent dosing schedule. The present invention also provides a method of treating tumor in a patient comprising administering a combination of a CD40 agonist antibody and a DNA replication inhibitor. Also provided is a formulation for use in the treatment.
    Type: Application
    Filed: July 14, 2009
    Publication date: December 17, 2009
    Inventors: Ronald P. Gladue, John D. Cusmano, Vahe Bedian
  • Uses of anti-insulin-like growth factor 1 receptor antibodies
    Publication number: 20040202651
    Abstract: The present invention relates to a therapeutic method comprising administering anti-IGF-IR antibodies, particularly human anti-IGF-IR antibodies to a subject for the treatment of certain disorders preferably in conjunction with administration of another therapeutic agent. The invention further relates to pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for treatment.
    Type: Application
    Filed: February 10, 2004
    Publication date: October 14, 2004
    Applicant: Pfizer Inc.
    Inventors: Bruce D. Cohen, Vahe Bedian, Mihail Obrocea, Jesus Gomez-Navarro, John D. Cusmano, Huifen F. Wang, Deborah J. Guyot, Kelly L. Page